Articles On Medlab Clinical (ASX:MDC)

Stockhead’s Prepped and Primed video series is a summary of development plans from company leaders, who share what investors can expect to see in the year ahead. In this instalment Dr Sean Hall, Chief Executive Officer at Medlab (ASX:MDC),...

Medlab says the study demonstrated a good safety, tolerability, and sustainability profile for its lead drug, NanaBis.  Medlab (ASX:MDC) has just announced favourable interim readouts of its NanaBis real world evidence (RWE) Medcare Observa...

Penington Institute says pot-related law enforcement costs us $1.7 billion a year   Local cannabis is missing out on international and domestic market opportunities Aussie medicinal cannabis revenue was around $230 million in 2021   Decri...

The ASX puts on a late spurt to finish the day up 0.5% Star Entertainment and Bluescope in very hot water  Patriot Lithium grows 95% on stunning debut, because… lithium. Obviously. Welp… that’s it for the final day of the week, and as te...

Global share markets rally continue to rally in November despite ongoing economic and geopolitical pressures Avenira led the gainers in November after reporting a positive update on its proposed DSO Phosphate Project Gut health company Mic...

ASX health stocks have been out of favour this year with rotation away from growth to value sector Morgan’s Scott Power said a lot of biotechs aren’t able to convert their complex science into layman’s terms Hot money going to lithium and...

Medlab Clinical’s key NanoCelle technology has completed another major milestone on the path to commercialisation with potential for needle-free delivery of mRNA vaccines and insulin for diabetes. Aussie biotech Medlab Clinical (ASX:MDC) h...

Two more US states join the 19 that already allow legal recreational cannabis use ECS Botanics’ Victorian medical cannabis facility is safe from flooding in the state, so far Cann looks to commercialise its Satipharm CBD capsules for over-...

It’s quarterlies season as the ASX market announcements page becomes increasingly flooded with lodgements. Cybersecurity, biotech and adtech companies were some that posted positive results today. Here’s some of the reports which have caugh...

Germany looks to legalise recreational cannabis and US and Canadian companies are paying attention  Neurotech reports success with its cannabis-based drug for paediatric autism symptoms  ECS Botanics has sold its Tasmanian business and a...

We take a look at how the 15 biotech IPOs that listed in 2021 are faring now Only two IPO stocks from 2021 have gained since listing We also look at the best and worst performing ASX stocks over the past month   There were 191 ASX IPOs in...

Welcome back class to Part 2 of our Clinical Trials 101. When it comes to healthcare and life sciences investing there is one area where investors should take notice and that is research and clinical trials.  An understanding of how the tri...

Blood clot programs have taken the spotlight recently as new discoveries made Two ASX health stocks are in the blood clot space Top performing ASX healthcare stocks in the past month Blood clots were top of biotech news this week after re...

Cambridge says cannabis smokers are not actually lazy, that’s a myth USyd wants to test home-grown cannabis in the ACT Incannex joins the big leagues S&P/ASX300 index   It turns out that the lazy stoner stereotype is actually a myth,...

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((AMX)) - Aerometrex ((AGI)) - Ainsworth Game Technology ((ALX)) - Atlas Arteria ((AUA)) - Audeara ((AMI)) - Aurelia Metals ((AVG)) - Australian Vintage ((DEL)) - Delorean...

Researchers say data shows transition from illicit to legal use of cannabis Medicinal users are at 37%, compared to 2.5% in 2018 Regulations, quality control and costs still barriers for legal week users   New research from the University...

Ice-T is opening a cannabis dispensary in New Jersey this year Snoop Dogg’s venture capital firm led a seed funding round for TSUMo Snacks Incannex ramps up development and manufacturing of IHL-216A drug New Jersey has given Ice-T the gre...

Medlab Clinical’s protection of its NRGBiotic has been given a win with formal acceptance of a depression patent in Europe. Aussie biotech Medlab Clinical (ASX:MDC) has announce that  the European Patent Office has formalised acceptance of...

Medlab Clinical’s (MDC) patent for depression is formally accepted by the European Patent Office The depression patent secures work completed by Medlab in an Australia depression trial, specifically around certain drug substances and their...

Medlab Clinical’s NanoCelle technology is changing the way medicine is delivered for better patient outcomes. So, what exactly is NanoCelle and how is it set to improve medicine delivery?  Ensuring the active pharmaceutical ingredient (API...

ASX benchmark ends 0.6% ahead Peregrine’s gold rush slows, but still up more than 85% for the day The UK is looking awesome, if you’re a fan of recessions The ASX has had a pretty stable afternoon today, after the ASX 200 rose to a 0.5% g...

July a great month for stocks — ASX200 had its best month since March, Emerging Companies (XEC) gained an eye-watering +14% Copper explorer Cobre stands tall as broader mining and exploration sector wilts Standout sector was Buy Now Pay La...

It’s quarterlies season as the ASX market announcements page becomes increasingly flooded with lodgements. The last day for companies to submit reports is the last business day of the first month after the prior quarter. If they don’t, they...

Mysterious pink glow over Mildura Thailand businesses go nuts for CBD desserts and bubble tea ECS nabs $2m commercial loan facility to invest in new capacity ICYMI a mysterious pink glow above Mildura sent residents into a bit of a frenzy...

US FDA approves the first clinical trial using naturally derived psychedelic drugs It could open possibilities for other clinical trials to follow suit Best and worst biotechs over the past month In a ground-breaking development, the US F...

Sean Hall of Medlab Clinical speaks at the Switzer Small and Micro Cap Investor Strategy Day 2022.

ECS is selling its medicinal cannabis farm in Tasmania Crypto ATMs are now a thing in weed dispensaries in the US Zelira Therapeutics nabs regulatory approval in Germany for insomnia medication Ever fancied your own cannabis farm? Well, t...

A recent research reveals which biotech segments VCs are ploughing billions of dollars into We list the ASX companies that are operating within those thematics We also list the best and worst ASX biotech performers over the past week and m...

Retail and independent cannabis lounges could be opening soon in Vegas Cann Group gets good manufacturing practice (GMP) licence for its Mildura facility Bod plans to launch a low dose CBD schedule 3 product into the Australian market  ...

Medlab clinical has laid out its road map to a dual listing on the Nasdaq to help open up greater access to capital pools and strengthen its position as an advanced biotech in the world’s largest market. The Australian biotech, which specia...

The ASX200 makes it four gains in a row The small cap index remains uninspired despite some strong individual performances HRL and 4DX deliver huge returns on Tuesday   The benchmark XJO is up by 0.6%. The little XEC index is not. The ASX...

University of South Australia research has shown promising results into Medlab’s key technology to improve delivery of medicines for greater effectiveness. Australian biotech Medlab Clinical (ASX:MDC), which specialises in nano-particle del...

The ASX200 is up for a 6-week high today of 2% today US and EU share markets were up 3% and 2.6% respectively on Friday The energy and tech sectors led the charge, followed by financials   Take your mind off rising inflation and surging i...

Aussie biotech Medlab Clinical (ASX:MDC) has just nailed a game-changing South East Asian distribution deal, opening the region up to its branded nutraceutical brands in the key target market. The Aussie-listed MDC, which specialises in usi...

ASX is set to open higher this morning US Fed Jerome Powell says a US recession is a ‘possibility’ Bitcoin slips below US$20k again, says get me off this ride The ASX is set to open higher by 0.40% this morning despite a fall on Wall Stre...

A Thai university says adding cannabis to chicken feed has positive results on meat and egg quality Aussie cannabis campaigner now a Member of the Order of Australia MGC Pharma’s CBD treatment proves effective against brain tumors   Chian...

Over the past decade, opioid-induced deaths were more likely to be due to prescription drugs than illegal drugs As scientists discover new ways to use the plant’s medicinal compounds, cannabis is seen as a possible solution to the opioid c...

Boston Beer Co launches cannabis iced tea in Canada University of Sydney says using CBD and driving is no worries Emyria reports positive Phase 1 study results for ultra-pure CBD capsule The Boston Beer Co is launching a line of cannabis-...

Highlights Medlab has added a new delivery path to its NanoCelle® Nasal nucleic acid (mRNA/SiRNA) program. NanoCelle® is a patented delivery platform of Medlab ® designed to address known medication problems. The NanoCelle® delivery p...

Actor Woody Harrelson has opened a cannabis store in West Hollywood Releaf has plans for a weed wellness retreat in Byron Bay Incannex wants to buy out APIRx   It’s not surprising that Woody Harrelson loves weed – the actor was actually...

Actor and cannabis farmer Jim Belushi is headlining the Grow Up Conference and Expo next month Franchise Global Health has established the first legal seedbank in Denmark Botanix nabs FDA Qualified Infection Disease Product designation for...

Central Banks have their fingers on the fun button this week, and the markets are pricing in the big push. The Emerging Companies Index (XEC) has been sunk on day dot, down 2.3%. The S&P/ASX 200 index was down 1.2% at 4.15pm, with this...

The Healthcare sector has been struggling as the pandemic wanes But most money managers are still bullish on the sector The biggest movements and news from ASX healthcare stocks this week  Dr Anthony Faucci, America’s top infectious disea...

The TGA down-scheduled low dose CBD in February for over-the-counter sales without a prescription Currently no CBD drugs have been approved for sale in Australia Cann Group reckons S3 registration could open the door to millions of patient...

The ASX healthcare sector rebounds on back of $20 billion Ramsay Healthcare takeover bid Volpara founder and CEO steps into new role as female CEO takes the reins Medlab Clinical shares soar after UK trade deal for probiotic for patients...

US Seed Connect launched Cannabis Crypto Seed Headz NFT Washington launches week-long cannabis tax holiday Medlab clinical makes moves in the Northern Hemisphere with manufacturing deal Wednesday was 4/20 day – while it’s more of an unoff...

Medlab Clinical (ASX:MDC) has announced a northern hemisphere trade deal with the former contract manufacturer of NRGBiotic.

Highlights Medlab Clinical has signed a three-year deal with Cultech Limited for NRGBiotic. Cultech will continue exclusive manufacturing of NRGBiotic for its PRO-VEN range. The deal opens opportunities in the UK pharmacies and health...

Medlab Clinical share price is soaring ~13.40% today to 11 cents on the back of a trade deal with UK’s Cultech Limited for its NRGBiotic. Australian biotech Medlab Clinical (ASX:MDC) has opened up a massive new northern hemisphere trade fr...

The healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak market appetite  A snapshot of the return of recent ASX Healthcare IPO stocks We are currently in the longest and steepest bear market for biot...